|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005516,
umls-concept:C0006142,
umls-concept:C0019932,
umls-concept:C0024202,
umls-concept:C0032854,
umls-concept:C0033325,
umls-concept:C0279781,
umls-concept:C1418596,
umls-concept:C1516213,
umls-concept:C1561558,
umls-concept:C2613365
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-9-10
|
|
pubmed:abstractText |
In this study, we evaluated if PITX2 DNA methylation is a marker for disease recurrence in lymph node-negative (LNN), steroid hormone receptor-positive (HR+) breast cancer patients. In addition, we studied the association between PITX2 DNA methylation and PITX2 gene expression.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0167-6806
|
|
pubmed:author |
pubmed-author:Bolt-de VriesJoanJ,
pubmed-author:DietrichDimoD,
pubmed-author:FoekensJohn AJA,
pubmed-author:HarbeckNadiaN,
pubmed-author:HartmannOliverO,
pubmed-author:KlijnJan G MJG,
pubmed-author:KluthAntjeA,
pubmed-author:KoenigThomasT,
pubmed-author:LescheRalfR,
pubmed-author:LookMaxime PMP,
pubmed-author:MagdolenViktorV,
pubmed-author:MaierSabineS,
pubmed-author:MartensJohn W MJW,
pubmed-author:Meijer-van GelderMarion EME,
pubmed-author:NimmrichInkoI,
pubmed-author:PortengenHenkH,
pubmed-author:SchmittManfredM,
pubmed-author:SchwopeInaI,
pubmed-author:SieuwertsAnieta MAM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
111
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
429-37
|
|
pubmed:meshHeading |
pubmed-meshheading:17965955-Adult,
pubmed-meshheading:17965955-Aged,
pubmed-meshheading:17965955-Breast Neoplasms,
pubmed-meshheading:17965955-Cell Line, Tumor,
pubmed-meshheading:17965955-DNA Methylation,
pubmed-meshheading:17965955-Female,
pubmed-meshheading:17965955-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:17965955-Homeodomain Proteins,
pubmed-meshheading:17965955-Humans,
pubmed-meshheading:17965955-Lymph Nodes,
pubmed-meshheading:17965955-Middle Aged,
pubmed-meshheading:17965955-Neoplasm Metastasis,
pubmed-meshheading:17965955-Prognosis,
pubmed-meshheading:17965955-RNA, Messenger,
pubmed-meshheading:17965955-Receptors, Steroid,
pubmed-meshheading:17965955-Retrospective Studies,
pubmed-meshheading:17965955-Survival Analysis,
pubmed-meshheading:17965955-Time Factors,
pubmed-meshheading:17965955-Transcription Factors,
pubmed-meshheading:17965955-Tumor Markers, Biological
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients.
|
|
pubmed:affiliation |
Department of Biomedical Research and Development and Technology Development, Epigenomics AG, Berlin, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
